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Reverse signaling by ephrin-As upon binding EphAs
controls axon guidance and mapping. Ephrin-As are
GPI-anchored to the membrane, requiring that they
complex with transmembrane proteins that trans-
duce their signals. We show that the p75 neurotro-
phin receptor (NTR) serves this role in retinal axons.
p75NTR and ephrin-A colocalize within caveolae
along retinal axons and form a complex required for
Fyn phosphorylation upon binding EphAs, activating
a signaling pathway leading to cytoskeletal changes.
In vitro, retinal axon repulsion to EphAs by ephrin-A
reverse signaling requires p75NTR, but repulsion to
ephrin-As by EphA forward signaling does not.
Constitutive and retina-specific p75NTR knockout
mice have aberrant anterior shifts in retinal axon
terminations in superior colliculus, consistent with
diminished repellent activity mediated by graded
ephrin-A reverse signaling induced by graded collic-
ular EphAs. We conclude that p75NTR is a signaling
partner for ephrin-As and the ephrin-A- p75NTR com-
plex reverse signals to mediate axon repulsion
required for guidance and mapping.
INTRODUCTION
Axonal connections in the mature nervous system are extraordi-
narily precise. To develop this precision, axons respond to
a complex environment of guidance cues as they pathfind and,
once within their target, to form an orderly set of connections
termed a topographic map. Diverse protein families affect axon
pathfinding and mapping, including but not limited to semaphor-
ins, Wnts, neurotrophins, ephrins, and their cognate receptors
(Tessier-Lavigne and Goodman, 1996; Huber et al., 2003;
McLaughlin and O’Leary, 2005; Flanagan, 2006). In addition, sig-
naling from diverse families of guidance molecules must con-
verge to provide coherent guidance information. Though axon
guidance systems eventually link to the cytoskeleton, distinct
families of guidance molecules and receptors likely interact at
multiple points in their signaling pathways, from ligand binding746 Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc.to intramembrane interactions to cytoskeletal alterations (Grun-
wald and Klein, 2002; Kullander and Klein, 2002; Murai and Pas-
quale, 2003).
Here, we use the developing mouse visual system to address
the potential for unique interactions between distinct families of
potential axon guidance molecules at the origin of signaling
events: the axon membrane. Specifically, we examine interac-
tions between the Eph/ephrin families, which have prominent
roles in map development (McLaughlin and O’Leary, 2005;
Flanagan, 2006), and the p75 neurotrophin receptor (p75NTR;
hereafter referred to as p75), a transmembrane protein known
for its role in activating signaling pathways for apoptosis and
cell survival by differentially interacting with the Trk family of
NTRs and neurotrophins (Chao, 2003; Huang and Reichardt,
2003; Barker, 2004).
Eph receptor tyrosine kinases and their ligands, the ephrins,
are prominent axon guidance molecules. Ephs and ephrins are
each separated into A and B subclasses that exhibit promiscu-
ous receptor-ligand binding and activation within each subclass,
but little between subclasses (Gale et al., 1996). All Eph recep-
tors, as well as ephrin-Bs, are transmembrane proteins, whereas
ephrin-As are GPI-linked to the cell membrane. In addition,
EphB-ephrin-B binding can result in bidirectional signaling, char-
acterized by not only ‘‘forward’’ signaling into cells that express
EphBs but also ‘‘reverse’’ signaling into ephrin-B-expressing
cells. Reverse signaling by ephrin-Bs is accomplished by asso-
ciation of the intracellular domain of ephrin-Bs with intracellular
kinases and phosphatases (Cowan and Henkemeyer, 2002; Kul-
lander and Klein, 2002). EphAs and ephrin-As can also transduce
signals bidirectionally, indicating that ephrin-As reverse signal
even though they lack an intracellular domain (Davy et al.,
1999; Davy and Robbins, 2000; Huai and Drescher, 2001). Re-
verse signaling by ephrin-As has been implicated in the pathfind-
ing of vomeronasal (Knoll et al., 2001) and spinal motor axons
(Marquardt et al., 2005) and the topographic mapping of the
axons of olfactory neurons (Cutforth et al., 2003) and retinal gan-
glion cells (RGCs; Rashid et al., 2005).
Because ephrin-As are anchored to the cell membrane by
a GPI linkage and lack an intracellular domain, to reverse signal
they must associate with transmembrane proteins capable of
activating intracellular signaling pathways. Examples of such as-
sociations between GPI-anchored proteins and transmembrane
signaling partners in neurons include the transmembrane protein
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(Peles et al., 1997) and binding of GDNF to the receptor complex
formed by the GPI-anchored receptor GFRa1 and the trans-
membrane protein c-Ret (Jing et al., 1996; Trupp et al., 1998).
However, a transmembrane signaling partner for ephrin-As has
not been reported.
As a model for ephrin-A reverse signaling, we have studied the
guidance of RGC axons and their formation of a topographic
map in the superior colliculus (SC). Ephrin-As are localized tomi-
crodomains in the membrane, termed caveolae, which serve as
platforms to localize signal transduction by selectively concen-
trating proteins and facilitating assembly of signaling complexes
(Davy et al., 1999; Simons and Toomre, 2000). An enhanced
phosphorylation of the Src-family kinase, Fyn, enriched in caveo-
lae has been implicated in ephrin-A reverse signaling and
concomitant changes in cytoskeletal architecture to affect cell
adhesion (Davy et al., 1999; Davy and Robbins, 2000). Similar
to ephrin-As, p75 also localizes to caveolae (Higuchi et al.,
2003) and is expressed by RGCs during the developmental
period of RGC axon guidance and mapping (Harada et al.,
2006). Thus, p75 is a candidate to complex with ephrin-As and
initiate their reverse signaling.
The temporal-nasal (T)-(N) axis of the retina maps along the
anterior-posterior (A)-(P) axis of the SC. During development,
RGC axons differentially respond in a manner relating to their or-
igin along the TN retinal axis to opposing gradients of repellent
activities along the AP axis of the SC, resulting in their retinotopic
mapping (Yates et al., 2004). The low-to-high AP gradient of
repellent activity is due to EphA forward signaling, controlled
by a high-to-low TN gradient of EphA receptors on RGC axons
and a low-to-high AP gradient of ephrin-As in the SC (reviewed
in McLaughlin and O’Leary, 2005; Flanagan, 2006). Computa-
tional modeling indicates that, in addition to this low-to-high
AP gradient of repellent activity, retinotopic mapping requires
an opposing high-to-low AP gradient of repellent activity (Yates
et al., 2004). Recent studies in mice have shown that the oppos-
ing gradient of repellent activity is due to ephrin-A reverse signal-
ing controlled by a high-to-low NT gradient of ephrin-As on RGC
axons and a high-to-low AP gradient of EphAs in the SC (Rashid
et al., 2005). Among the findings showing this role for ephrin-A
reverse signaling are that RGC axons avoid substrates contain-
ing EphA7 in vitro and that genetic deletion of EphA7, which is
expressed in a high-to-low AP gradient in the SC but is not ex-
pressed in retina, results in aberrant retinocollicular mapping
(Rashid et al., 2005).
We hypothesize that ephrin-As and p75 associate in caveolae
along RGC axons and that p75 transduces the ephrin-A reverse
signal that repels RGC axons and is required for proper APmap-
ping in the SC. Supporting this hypothesis, we show that p75,
ephrin-As, and EphAs are expressed in appropriate patterns
by RGCs and in the SC, that p75 colocalizes with ephrin-As in
caveolae along RGC axons, and that ephrin-As and p75 form
a complex. Further, we show that p75 is required for EphA7 to
induce a significant increase in the phosphorylation of Fyn in
caveolae, indicating that the Fyn signaling pathway associated
with ephrin-A reverse signaling is p75 dependent. In vitro guid-
ance assays show that p75 is required for retinal axons to be re-
pelled by EphAs. In addition, we show, using constitutive andconditional p75 knockout mice, that RGC axons deficient for
p75 aberrantly map anterior to their correct targets, as predicted
for a diminished repellent effect of ephrin-A reverse signaling.
We conclude that p75 acts as a signaling partner with ephrin-
As to mediate the repellent effect of ephrin-A reverse signaling
on RGC axons upon binding EphAs and that this signaling is
required for appropriate retinotopic mapping.
RESULTS
Distributions of EphAs, Ephrin-As, and p75
in Developing Retinocollicular Projection
Previous reports have demonstrated the expression of ephrin-As
in gradients in the embryonic and postnatal retina (McLaughlin
and O’Leary, 2005). In addition, multiple EphAs are expressed
in gradients in the SC (Rashid et al., 2005). For the purpose of
our study, we analyzed protein distribution of ephrin-As in the
retina and EphAs in the SC at P2, the midpoint in development
of retinotopic map in the SC. Immunostaining for ephrin-A5
and ephrin-A2 reveals that each is expressed in a high-to-low
NT gradient in the retina, including by RGCs (Figures 1A and
1B). The gradient of ephrin-A5 is steep and restricted primarily
to nasal retina, whereas the ephrin-A2 gradient is shallow but ex-
tends across most of the NT retinal axis. In addition, both ephrin-
A5 and ephrin-A2 are present along RGC axons as they exit the
retina and form the optic nerve (Figure 1A and data not shown).
To determine the distribution of EphA protein in the SC at P2,
we used an ephrin-A5-Fc affinity probe that binds to all EphAs
and is detected by Fc-specific antibodies (Figure 1C). We find
that EphAs are distributed in an overall high-to-low AP gradient
in superficial layers of the SC where RGC axons navigate across
the AP axis of the SC as well as arborize.
p75 is expressed by RGCs throughout development of the ret-
inocollicular projection (Harada et al., 2006). By specific immu-
nostaining, we find that at P2 p75 protein is distributed across
the retina with no obvious gradient and is present in RGCs and
along RGC axons (Figures 1D and 1E). We find similar distribu-
tions of p75 protein at E16, when the first RGC axons reach
the SC, through at least P8, when the retinocollicularmap resem-
bles its mature form (data not shown). Thus, p75 is distributed
along RGC axons at the appropriate time to mediate ephrin-A
reverse signaling during their guidance and mapping.
To investigate colocalization of p75 and ephrin-A proteins
along RGC axons, we performed immunohistochemistry on pri-
mary cultures of dissociated mouse retina. A punctate distribu-
tion of both p75 and ephrin-A5 in microdomains that resemble
caveolae is found along the primary axon shaft, branches, and
growth cones of RGCs (Figures 1F and 1F0). Domains of p75 of-
ten colocalize with domains of ephrin-A5 and ephrin-A2, though
nonoverlapping domains are also evident (Figure 1F00; data not
shown). This colocalization of p75 and ephrin-As in caveolae-
like domains along RGC axons is consistent with the distribution
required for their biochemical association.
p75 Associates with Ephrin-As and Is Required
for Their Reverse Signaling
To establish whether p75 and ephrin-As associate in protein
complexes, we carried out a series of immunoprecipitationNeuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc. 747
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bodies against either p75 or ephrin-A2 results in the coimmuno-
precipitation of ephrin-A2 and p75, respectively (Figure 2A). We
also analyzed PC12 cells, which endogenously express p75,
stably transfected with ephrin-A2 linked to the V5 epitope (V5-
ephrin-A2). Immunoprecipitation using an antibody specific for
p75 (the ‘‘Buster’’ intracellular domain antibody) pulls down
V5-ephrin-A2, and a V5 antibody for the tagged ephrin-A2 pulls
down p75 (Figure 2B). We also examined the distributions of
ephrin-As and p75 on transfected cells in vitro. In 293 cells trans-
Figure 1. Retinal Expression and Colocalization of p75 and
Ephrin-As
(A–E) Cryosections at 20 mm of P2 wild-type mouse stained with DAPI to label
nuclei (blue). (A and B) Retina immunolabeled with (A) anti-ephrin-A5 (red) and
(B) anti-ephrin-A2 (red). Ephrin-A5 and ephrin-A2 are present in the ganglion
cell layer (GCL; arrows), retinal ganglion cells (RGCs), RGC axons, and the
optic nerve (on). Ephrin-A5 and ephrin-A2 are present in a high-to-low nasal
(N) to temporal (T) gradient. (C) Sagittal section through superior colliculus
(SC) labeled with ephrin-A5-Fc affinity probe. EphAs are in a high-to-low ante-
rior (A) to posterior (P) gradient in superficial layers of SC (arrow; red). (D and E)
Retina immunolabeled with anti-p75 shown at low (D) and high (E) magnifica-
tion. p75 (red) is present throughout retina, including the GCL, RGC axons
(arrows), and optic nerve.
(F–F00) Mouse retinal axon in vitro double labeled with (F) anti-p75 and (F0) anti-
ephrin-A5. Discrete domains of p75 and ephrin-A5 on the cell body (asterisks)
and its processes are evident. (F00) Overlap of p75 (green) and ephrin-A5 (red)
labeling demonstrates their colocalization (yellow; arrows), though clear
domains of each are visible (arrowhead). Colocalized domains are in close
proximity to domains of p75 and ephrin-A5 (inset). Scale bar, 50 mm in
(A)–(D), 15 mm in (E), 8 mm in (F)–(F00).748 Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc.fected with cMyc-tagged p75 or V5-ephrin-A5, EphA7-Fc binds
only those cells expressing ephrin-A5, indicating that EphA7 it-
self does not bind p75 extracellularly (Figure 2C). In addition,
we find that ephrin-A5 and p75 are found in discrete caveolae-
like puncta on the cell membrane, similar to their distributions
along RGC axons. Immunoprecipitations and western blots per-
formed on 293T cells transiently cotransfected with cMyc-p75
and either V5-ephrin-A5 or V5-ephrin-A2 using antibodies
directed against either the cMyc or V5 epitopes coimmunopreci-
pitate p75 with either ephrin-A2 or ephrin-A5 (Figure 2C). Thus,
these findings using cell lines corroborate those obtained with
mouse retina and together suggest that ephrin-As and p75 are
present as a protein complex in the membrane. This association
between p75 and ephrin-As, together with their colocalization in
discrete domains along RGC axons, suggests functional impli-
cations for p75-ephrin-A complexes in activating intracellular
signaling, in response to EphAs, that controls RGC axon guid-
ance and mapping.
Fyn has been implicated in ephrin-A reverse signaling (Davy
et al., 1999). Therefore, we performed experiments to determine
whether p75 is involved in the Fyn signaling pathway associated
with ephrin-A reverse signaling. We first established that EphA7-
Fc binds ephrin-As but does not bind p75 on the surface of trans-
fected 293 cells (Figure 2C), indicating that EphA7 is not a ligand
for p75 but is a ligand for ephrin-A. Although p75 does not bind
EphAs, we show below that the association of p75 with ephrin-A
is required for ephrin-A reverse signaling.
We next examined the phosphorylation of Fyn in stably trans-
fected 293 cells to determinewhether Fyn phosphorylation asso-
ciated with ephrin-A reverse signaling is dependent upon p75.
Previous studies of ephrin-A reverse signaling in transfected
cell lines have shown that the enhanced phosphorylation of
Fyn occurs predominantly in the caveolae fraction, with a very
minor increase in the soluble fraction (Davy et al., 1999). These
findings are consistent with the preferential localization of
ephrin-As and p75 to caveolae (Davy et al., 1999; Higuchi
et al., 2003; present study). Therefore, we focused on caveolae-
containing fractions isolated from stably transfected 293 cells
and identified with antibodies against the caveolae-specific pro-
tein, flotillin-1 (Higuchi et al., 2003; Slaughter et al., 2003), and
the presence of the caveolae-specific lipid, GM1 (Parton, 1994;
Figure 3). We used EphA7-Fc to stimulate ephrin-A reverse
signaling by its binding of ephrin-A, and as a control for this stim-
ulation, we used Fc alone. These are the same proteins that we
use in the protein stripe assay, described in the following section,
to show that the repellent effect of ephrin-A reverse signaling on
retinal axons is dependent upon p75.
We find that in cells stably transfected with either ephrin-A2 or
p75, the level of phosphorylated Fyn or even overall phosphotyr-
osine levels do not change after treatment with EphA7-Fc com-
pared to Fc treatment (Figures 3A and 3B). However, when both
ephrin-A2 and p75 are present, we find a significant increase in
the overall level of both phosphotyrosine and Fyn after treatment
with EphA7-Fc, compared to treatment with Fc, in the caveolae
fractions (n = 2; Figure 3C). These data indicate that p75 com-
plexes with ephrin-As and is required for activation of ephrin-A
reverse signaling through an intracellular pathway involving
Fyn. Interestingly, we also find that the level of p75 is increased
Neuron
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pared to Fc treatment, in cells in which ephrin-A2 is also present.
In addition to the substantial increase in phosphotyrosine level
induced by EphA, the findings that the recruitment of p75 and
Fyn to caveolae is also dependent on EphA binding ephrin-A
supports their involvement in ephrin-A reverse signaling.
Repellent Effect of EphA7 on Retinal Axons
Requires p75
We used the protein stripe assay to assess whether the repellent
activity of ephrin-A reverse signaling for retinal axons requires
their expression of p75. Axons extending from retinal explants
from P0 wild-type (p75+/+) and p75 knockout mice (p75/;
Lee et al., 1992) were given a choice to grow on alternating
stripes of EphA7-Fc and Fc, or in control experiments, alternat-
ing stripes that each contain Fc (Figure 4). We chose EphA7 be-
cause it is expressed in a high-to-low AP gradient in the SC and
repels wild-type retinal axons in the protein stripe assay (Rashid
et al., 2005). In control experiments, neither p75+/+ nor p75/
retinal axons exhibit a growth preference for either set of Fc
stripes (Figures 4A and 4B). However, when given a choice
between alternating stripes of EphA7-Fc and Fc, p75+/+ retinal
axons demonstrate a strong preference for stripes containing
Fc and a strong avoidance of stripes containing EphA7-Fc (Fig-
ure 4C). In contrast, p75/ retinal axons do not exhibit a signifi-
cant preference for either the EphA7-Fc or Fc set of stripes and
Figure 2. Ephrin-As and p75 Are Present
in the Same Complex
(A) Retina fromwild-type and p75 null mutant mice
immunoprecipitated (IP) with anti-p75 antibody
(Buster) or anti-ephrin-A2 antibody (R&D sys-
tems). Western blots (WB) reveal that p75 and
ephrin-A2 co-IP.
(B) PC12 cells and PC12 cells stably transfected
with V5-ephrin-A2 immunoprecipitated with the
antibody indicated. Western blots demonstrate
that p75 (endogenously expressed by PC12 cells)
and V5-ephrin-A2 co-IP.
(C) Triple-immunolabeled 293 cells transfected
with V5-ephrin-A2 or cMyc-p75. Cells were incu-
bated with EphA7-Fc and triple labeled with anti-
bodies against cMyc, V5, and Fc. Both p75 (red,
arrowhead) and ephrin-A2 (blue) are in a punctate
distribution on distinct cells. EphA7-Fc (green, ar-
row) labels only cells transfected with V5-ephrin-
A2. Cells are also stained with DAPI (white; nuclei).
Western blots after IPs with the antibodies listed
on 293T cells transiently transfected with the con-
struct(s) indicated (+) demonstrate that ephrin-A2
and ephrin-A5 co-IP with p75.
Figure 3. EphA-Induced Fyn Phosphoryla-
tion in Caveolae Requires p75
(A–C) Stably transfected V5-ephrin-A2, p75, and
V5-ephrinA2/p75 293 cells treated with Human-
Fc (2 mg/ml) or EphA7-Fc (2 mg/ml) for 10 min at
37C. Cells were lysed and fractionated through
a sucrose gradient (see Experimental Procedures).
The presence of the caveolae (cav) associated
protein flotillin-1, detected with an anti-flotillin-1
antibody, and GM1, detected with CTX-HRP in
a dot blot, indicates the fractions containing cav-
eolae. Tyrosine phosphorylation (p-Tyr; 4G10 anti-
body) in the caveolae fractions is unchangedwhen
challenged with EphA7-Fc compared to Fc in both
the (A) ephrin-A2 cell line and the (B) p75 cell line.
(C) In contrast, the ephrin-A2/p75 cell line has
a higher level of p-Tyr in caveolae fractions (arrow-
heads) when treated with EphA7-Fc compared to
Fc alone (arrows). The largest increase in p-Tyr
(arrowheads) is coincident with the location of
Fyn on the reprobed blot (hollow arrowheads).Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc. 749
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qualitative impressions of the growth preferences are supported
by three distinct quantitative methods, all performed blind to ge-
notype and stripe content, that include the classic method of
scoring growth preference on a scale from 0 to 4 (Figure 5A;Wal-
ter et al., 1987), quantification of pixels representative of stained
axons on each set of stripes (Figure 5B), and a modified Sholl in-
tersection analysis (Sholl, 1953; Figures 5C and 5D) (see Exper-
imental Procedures for details).
We performed additional stripe assay experiments to assess
potential effects of p75 deficiency on the repellent effect of
EphA forward signaling in response to ephrin-As exhibited by
retinal axons. These experiments were carried out as described
Figure 4. Retinal Axons Require p75 for EphA7 Repulsion
(A–D) In vitro protein stripe assays demonstrating that wild-type RGC axons
preferentially avoid stripes containing EphA7 but p75/ RGC axons do not.
(A and B) Axons (green) extending on a control substrate of alternating stripes
of human-Fc and human-Fc (Fc). Axons do not show a growth preference for
one stripe over the other whether they extend from (A) a p75+/+ mouse retinal
explant or from (B) a p75/ retinal explant. (C and D) Axons extending on
a substrate of alternating stripes of human-Fc and EphA7-Fc (red; A7). (C)
Axons from a p75+/+ retinal explant preferentially extend on the human-Fc
stripes and avoid the EphA7 stripes. (D) In contrast, axons from a p75/ retinal
explant do not avoid stripes containing EphA7.
(E and F) Axons extending on a substrate of alternating stripes of human-Fc
and ephrin-A5-Fc (red; A5). Axons show a strong preference for the Fc-con-
taining stripes and avoid the ephrin-A5-containing stripes whether they extend
from (E) a p75+/+ retinal explant or from (F) a p75/ retinal explant. Scale bar,
200 mm.750 Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc.above except EphA7-Fc was replaced with ephrin-A5-Fc. We
find that p75+/+ retinal axons preferentially avoid ephrin-A5-con-
taining stripes (Figure 4E), consistent with previous reports (e.g.,
Feldheim et al., 1998), and that p75/ retinal axons also show
a strong avoidance of ephrin-A5 stripes (Figure 4F) indistinguish-
able from wild-type (Figures 5A and 5D). Therefore, p75+/+ and
p75/ retinal axons exhibit a similar repellent response to
ephrin-A5 mediated by EphA forward signaling.
In additional experiments, we titrated the concentration of
ephrin-A5-Fc in the stripes to the level at which p75+/+ retinal
axons exhibit a small but significant preference for the Fc set
of stripes (coefficient of choice = 0.22; p < 0.05; n = 9; see Exper-
imental Procedures). We find that matched sets of retinal ex-
plants from p75/ mice grown on the same substrates in the
same dish as the retinas from p75+/+ littermates exhibit a similar
degree of preference for the Fc stripes (coefficient of choice =
0.20; p < 0.05; n = 9; coefficients of choice are not significantly
different from each other). Thus, p75+/+ and p75/ retinal axons
exhibit the same degree of repulsion to ephrin-A5 at both high
and low concentrations of the repellent activity. These data indi-
cate that p75/ retinal axons are not only repelled by ephrin-A5
to a similar degree as p75+/+ retinal axons but that both exhibit
the same sensitivity to ephrin-A5. Thus, p75 deficiency does
not significantly influence EphA forward signaling in retinal axons
or mechanisms required for them to exhibit a repellent response.
We also find that p75+/+ and p75/ retinal axons do not ex-
hibit significant differences in general outgrowth. For example,
over all of the stripe experiments described, p75+/+ retinal
explants extend on average 26 axons, similar to p75/ retinal
explants that extend 25 axons (n = 47 for p75+/+; n = 37 for
p75/; n.s.). Similarly, the extent of axon growth is similar be-
tween genotypes. For example, 27% of all axons that extend
at least 100 mm from a retinal explant also extend 900 mm for both
p75+/+ and p75/ retinas (n = 1237 axons for p75+/+; n = 933
axons for p75/; n.s).
We conclude that the lack of avoidance of EphA7-Fc byp75/
retinal axons is not due to a general inability to extend or respond
to guidance cues but rather is due to a specific defect in ephrin-A
reverse signaling. Taken together, these data show that p75 me-
diates the repellent effect of EphAs on retinal axons and together
with our biochemical and colocalization data strongly suggest
that p75 is a signaling partner for ephrin-A reverse signaling.
Use of p75 Mutant Mice to Study Requirement
for p75 in Retinotopic Mapping
Our findings that p75 is required in vitro for the repulsion of retinal
axons by ephrin-A reverse signaling suggest that p75 is required
for the proper development of the retinotopic map in the SC. We
predict that in the absence of p75, repulsion of RGC axons me-
diated by ephrin-A reverse signaling will be diminished, resulting
in an anterior shift of their projections. To address this issue, we
used complementary axon tracing methods to analyze the topo-
graphic organization of the retinocollicular projection in constitu-
tive p75 knockout mice (Lee et al., 1992) and in conditional p75
knockout mice in which floxed (fl) alleles of p75 were selectively
deleted from RGCs localized to specific retinal domains (mouse
described in Z. Chen, T.-C. S., N. Harada,W. Lin, andK.-F.L., un-
published data). One labeling method is anterograde labeling of
Neuron
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(A) Average growth preference scores (error bars = SEM) for
retinal axons in the stripe assay (see Experimental Proce-
dures). A score of four is an essentially complete choice for
one stripe; a score of zero is no discernible choice for either
stripe. Retinal axons do not show a preference on control
human-Fc versus human-Fc (Fc) substrates. Retinal axons
from p75+/+ explants show significant avoidance of EphA7
compared to retinal axons from p75/ explants. In contrast,
axons extending from p75+/+ or p75/ explants avoid eph-
rin-A5 (A5) to a similar extent.
(B) The coefficient of choice for p75+/+ and p75/ axons
extending on control Fc versus Fc substrates or EphA7-Fc
versus Fc substrates is shown. Pixels representing axons
present in each stripe were quantified and the coefficient cal-
culated as the number of pixels on the Fc stripe minus pixels
on the second stripe (Fc or EphA7), divided by total pixels
(see Experimental Procedures). A coefficient of one is an
absolute choice for the control stripe, and a coefficient of
zero indicates no preference. p75+/+ axons preferentially avoid
EphA7 stripes, whereas p75/ axons do not show a signifi-
cant preference for Fc stripes compared to EphA7 stripes.
(C and D) Protein stripe assays analyzed with a simplified Sholl
intersection analysis. (C) Schematic demonstrates the analy-
sis method (see Experimental Procedures). All intersections
(arrowheads) between axons and lines at defined distances
from the explant edge were counted blind to genotype, stripe
content, and stripe position. (D) Coefficients of choice for in-
tersection points determined by the modified Sholl analysis
(intersections on the Fc stripe minus intersections on the sec-
ond stripe (Fc or EphA7 or ephrin-A5), divided by total inter-
sections). On Fc versus Fc substrates, there is no significant
choice for either stripe. In contrast, p75+/+ axons extending
on Fc versus EphA7 substrates intersect the Sholl lines signif-
icantly more often on Fc stripes than on EphA7 stripes. How-
ever, in p75/ axons, this preference is greatly reduced, and
the number of intersection points on Fc and EphA7 stripes is not significantly different. For both p75+/+ and p75/ axons extending on Fc versus ephrin-A5
substrates, significantly more intersection points occur on Fc stripes compared to ephrin-A5 stripes. n values in panel (A) apply to panels (B) and (D). n.s., not
significant; *p < 0.02, **p < 0.001.a small number of RGC axons by a small focal injection of the li-
pophilic axon tracer DiI in the retina. The other method labels, in
a reproducible manner, large domains of RGCs and their axonal
terminations using a conditional eGFP marker and the a-cre re-
combinase allele that is expressed in nasal and temporal retina
but not in central retina or along the visual pathway (Marquardt
et al., 2001; Baumer et al., 2002; data not shown).
We verified that the development, size, and patterning of the
retina are normal in the constitutive and conditional p75 mutants.
Markers specific forRGCs (e.g.,Brn3.2;Figures7Cand7C0; Xiang
etal., 1993), aswell asgeneral cell stains, reveal that at lateembry-
onic and postnatal ages the size and laminar patterning of the
retina, and density of RGCs, is indistinguishable between p75/
mice and their p75+/+ littermates (data not shown; also Harada
et al., 2006). Further, these genotypes have no difference in the
graded expression of ephrin-A2 and ephrin-A5, indicating that
expression of axon guidance molecules and axial patterning of
the retina is normal in the absence of p75 (data not shown).
Analyses of Constitutive Null p75 Mice
We first analyzed the topographic organization of the retinocollic-
ular projection in constitutive null p75 mice and their p75+/+ litter-
mates bymaking a small focal injection of DiI into peripheral nasalretina. At neonatal stages, prior to map refinement, the projec-
tions labeled in p75+/+ and p75/ mice are indistinguishable, in-
cluding the degree of axon overshoot (data not shown). By P8,
when the map is normally properly ordered (Frisen et al., 1998),
a nasal DiI injection in p75+/+ mice labels a dense, focal TZ in
the topographically appropriate position in posterior SC (n = 11;
Figure 6A). A similar nasal injection of DiI in p75/ mice results
in a dense, focal TZ, but in every case the TZ is shifted anteriorly
compared to its position in p75+/+ littermates (n = 8; Figure 6B).
Quantification shows that the positions of the DiI injection sites
on the TN retinal axis are not statistically different between geno-
types, but in contrast the anterior shift of the TZ formed by nasal
RGCaxons on the APSC axis in p75/mice compared to p75+/+
littermates is statistically significant (Figure 9A). Additionally, the
AP position of the TZ in each p75/ case is positioned anterior
to the mean TZ position for p75+/+ cases (Figure 9B).
In addition to an anterior shift in the TZ in p75/mice, in half of
the p75/ cases, ectopic branches and arbors are present
along the AP length of nasal axons in the SC at P8 (Figure 6B),
an age when the retinotopic map in p75+/+ mice is refined to
its mature form and branches are not observed outside the TZ.
To study the organization of the retinocollicular map at a popu-
lation level, the a-cre line, which expresses cre recombinase inNeuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc. 751
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Knockout Mice
(A) Dorsal view of the superior colliculus (SC) of a P8 wild-type
mouse after focal injection of DiI in nasal (N) retina reveals
a dense termination zone (TZ) in posterior (P, dotted line is
posterior SC border) SC. No interstitial branches are evident
in the SC outside of the TZ at this age in p75+/+ mice. Arrow-
heads mark the anterior (A) border.
(B) SC of a P8 p75/ mouse injected with DiI in nasal retina
(injection is similar in size and location to that in panel [A]) re-
veals a dense TZ in posterior SC, but shifted anteriorly (sTZ) in
comparison to wild-type. Multiple branches (arrows) and rudi-
mentary arbors (black arrowhead) are evident throughout the
SC, anterior to the TZ.
(C) Schematic describing the expression of cre-recombinase
in nasal and temporal retinal ganglion cells (RGCs; red) in
a-cre mice. The a-cre line in combination with the ROSA-
GAP43-eGFP (R-eGFP) line results in a stereotypic pattern
of eGFP-labeled RGC axons (green) in three distinct domains
in the SC, corresponding to the eGFP-labeled projection from
temporal (Td) and nasal (Nd) retina and the unlabeled central
domain (Cd).
(D) Dorsal view of the SC of a p75+/+; a-cre; R-eGFP mouse
illustrating the stereotypic pattern of R-eGFP in wild-type
mice. Bracket denotes the anterior-posterior extent of the Nd.
(E and F) RGC projections in p75/; a-cre; R-eGFP mice
show an anterior shift in nasal RGC axon mapping.
(E) Bracket denotes an extended, anteriorly shifted Nd.
(F) In some p75/ cases, the eGFP is discontinuous and has gaps (arrow), indicating a disorganized projection. These gaps are not observed in p75+/+; a-cre;
R-eGFP mice. L, lateral; M, medial. Scale bar, 400 mm.nasal and temporal retina but not in central retina (Marquardt
et al., 2001; Baumer et al., 2002), was crossed to the ROSA-
GAP43-eGFP line (R-eGFP) that requires cre-mediated deletion
of a floxed-stop cassette to express an eGFP reporter under con-
trol of theROSApromoter (Sapir et al., 2004). This strategy selec-
tively labels nasal and temporal retina, including RGC axons and
their terminations within the SC (Figure 6C). We crossed this
a-cre; R-eGFP compound line with p75 mutant mice to study
more broadly the effect of p75 deletion on retinotopic mapping.
In p75+/+; a-cre; R-eGFP mice, the projections of RGCs in the
nasal and temporal domains of retina are labeled by eGFP, re-
vealing the retinotopic pattern of their terminations, that include
a nasal domain (Nd) in posterior SC and a temporal domain (Td)
anterior SC, respectively, as well as an eGFP-negative central
domain (Cd) formed by the axonal terminations of RGCs in cen-
tral retina that do not express cre (n = 10; Figures 6C and 6D).
However, in p75/; a-cre; R-eGFP mice, the Nd of this termina-
tion pattern formed by eGFP-positive nasal RGC axons shows
a significant anterior expansion into the eGFP-negative Cd
formed by eGFP-negative central RGC axons (n = 7; Figures
6E and 6F). Further, in a subset of these p75/ cases, regions
of lower eGFP expression are evident in the Td (Figure 6F). These
regions of diminished eGFP expression are not observed in
p75+/+ littermates, indicating a level of disorganization in the ret-
inotopic map of p75/mice that likely reflects ectopic arboriza-
tions formed by eGFP-negative central RGC axons, consistent
with DiI labeling in p75/ mice.
To quantify these mapping changes in p75 mutants, we mea-
sured the relative mean areas occupied by each of the three pro-
jection domains (Nd, Cd, and Td) in the SC (Figure 9; see Exper-
imental Procedures). Compared to p75+/+ mice, the Nd shows752 Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc.a significant increase in area in the p75/ mice (13% increase,
p < 0.02), confirming an anterior shift in the TZs of p75-deficient
nasal axons. Consistent with this anterior shift, the Cd is dimin-
ished in size in p75/ mice compared to p75+/+ mice (27% de-
crease, p < 0.02). In summary, in p75/ mice, the terminations
of nasal RGC axons in the SC are shifted anteriorly to those in
p75+/+ mice. The total area of the SC is not significantly different
between genotypes (data not shown); thus, these differences in
the sizes of the termination domains are both relative and abso-
lute. This anterior shift of the terminations of RGC axons is
consistent with a diminished repellent effect of ephrin-A reverse
signaling due to their loss of the ephrin-A signaling partner, p75.
Analyses of Mice with Retina-Specific Deletion
of Floxed Alleles of p75
To further study the influence of p75 on retinotopic mapping
in vivo, we analyzed mice with a conditional allele (floxed, fl) of
p75 that can be removed by cre recombinase. For wild-type con-
trols, we used mice containing the p75 floxed allele but not the
a-cre allele (p75 fl/fl or p75 fl/+ and cre negative) and p75+/+;
a-cre; R-eGFP mice, none of which affect retinocollicular devel-
opment or mapping (data not shown). In p75+/+; a-cre; R-eGFP
mice, the nasal and temporal retina are labeled by eGFP without
affecting p75 expression (Figures 7A and 7A0). In p75 fl/fl; a-cre;
R-eGFPmice, eGFP is also expressed in nasal and temporal ret-
ina, but p75 protein is also selectively eliminated; cells in central
retina lack cre recombinase and therefore do not express eGFP
and retain wild-type levels of p75 protein (Figures 7B and 7B0).
This altered pattern of p75 protein distribution in p75 fl/fl; a-cre
mice is evident prior to E16, when RGC axons first reach the
SC, and thereafter.
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types as in p75/mice (Figure 8). Focal injections of DiI in nasal
retina of p75 fl/fl; cre-negative mice at P8 (n = 16) reveal a projec-
tion indistinguishable from wild-type mice (Figure 8A). However,
similar injections of DiI into retinas of p75 fl/fl; a-cre mice (n = 21)
reveal a TZ shifted anteriorly at P8 (Figure 8B), as observed in
p75/ mice. Quantification of the AP position of the TZ shows
a significant difference between p75 fl/fl; a-cre mice compared
to wild-type littermates, confirming the anterior shift of TZs
formed by p75-deficient nasal RGC axons (Figure 9A). Further,
the AP position of the TZ in every p75 fl/fl; a-cre case is posi-
tioned anterior to the mean TZ position for p75 fl/fl; cre-negative
mice (Figure 9B). In addition to this anterior shift of the TZ formed
by p75-deficient nasal RGC axons in p75 fl/fl; a-cre mice, in
a proportion of these cases the single focal DiI injection labels
a dual TZ, with a TZ in the appropriate position and an ectopic
TZ anterior to it (n = 3; Figure 8C).
Figure 7. Conditional Allele of p75 Is Excised with Cre Recombinase
(A and A0) Cryosection through a P2 p75+/+; a-cre; R-eGFP mouse. The nasal
(N) and temporal (T) aspects of the retina, including the ganglion cell layer
(GCL), are labeled with eGFP, mimicking cre expression. The distribution of
p75 is unaffected in p75+/+; a-cre; R-eGFP mice.
(B and B00) However, in p75 fl/fl; a-cre; R-eGFPmice, p75 protein is not detect-
able at P2 in nasal and temporal retina but is unchanged in central retina. The
eGFP label in panel (B) indicates the presence of cre-recombinase and, thus,
the cells in which p75 has been excised. The arrows are in the same position
and denote the border of eGFP expression.
(C and C0) Cryosection from the retina of a p75 fl/fl; a-cre; R-eGFP mouse
labeled for the RGC marker Brn3.2 at P2. The proportion of RGCs in central
retina, where p75 expression is unaltered, is identical to that in nasal and
temporal retina, where p75 is absent. Arrowheads denote the edges of cre
expression. Scale bar, 40 mm.
As described above, in p75+/+; a-cre; R-eGFP mice (n = 8;
Figure 8D), the R-eGFP labeling pattern reveals the retinotopic
map in the SC at a population level. As in p75/ mice, we find
a significant anterior shift of the Nd in the SC of p75 fl/fl; a-cre;
R-eGFP mice (n = 12; Figures 8E and 8F). In addition, numerous
holes are evident in the eGFP labeling pattern in the Td of the SC,
in contrast to the more uniform labeling in wild-type mice, indic-
ative of aberrant anterior terminations of RGC axons from the
eGFP-negative Cd. To quantify these mapping changes, we
again measured the relative mean areas occupied by each of
the three retinal projection domains in the SC. Outlines of the
projection domain borders for two representative wild-type
cases and a p75 fl/fl; a-cre; R-eGFP case demonstrate the ante-
rior shift of the Nd aswell as the variability in the overall projection
for p75mutant cases (Figure 9C). Overall, compared to wild-type
(i.e., p75+/+; a-cre; R-eGFP; n = 8), the Nd shows a significant in-
crease in area in the p75 fl/fl; a-cre; R-eGFP mice (n = 12), and
the Cd, which retains p75 and therefore p75-ephrin-A reverse
signaling, shows a concomitant statistically significant decrease
in area (Figure 9D). Because cre expression in the a-cre line is
Figure 8. Aberrant Retinocollicular Mapping in p75 Conditional Mice
(A) Dorsal view of the superior colliculus (SC) of p75 fl/fl; cre-negative mouse at
P8 after focal injection of DiI in nasal retina reveals a dense termination zone
(TZ) in posterior (P) SC (dotted line is posterior SC border; arrowheads mark
the anterior [A] SC border).
(B and C) SCs of p75 fl/fl; a-cre mice at P8 after focal injections of DiI in nasal
retina, similar in size and location to that in panel (A). (B) In every p75 fl/fl; a-cre
case, the TZ is shifted (sTZ) anteriorly compared to its expected position. (C) In
a subset of p75 fl/fl; a-cre mice, focal DiI injection reveals two TZs in posterior
SC. The arrow points to the appropriate location of the TZ, with an sTZ in an
anterior position.
(D) A p75+/+; a-cre; R-eGFP case illustrates the stereotypic pattern of the
eGFP-labeled temporal and nasal RGC axon projection domains (Td and Nd,
respectively). The projection domain from central retina (Cd) is unlabeled.
(E and F) In p75 fl/fl; a-cre; R-eGFP mice, the Nd is significantly expanded
anteriorly, and the Cd is significantly reduced. In many p75 fl/fl; a-cre;
R-eGFP cases, the eGFP is discontinuous and has a mottled appearance,
suggesting a disorganized map (arrow in [E]). L, lateral; M, medial. Scale bar,
400 mm.Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc. 753
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in p75 Mutant Mice
(A) Average position of the center of the DiI-labeled termination zones (TZs)
from the posterior pole of the superior colliculus (SC) in percent of the ante-
rior-posterior (AP) extent of the SC (error bars = SEM). There is a significant
anterior shift in TZ position for p75/ and p75 fl/fl; a-cre mice compared to
controls. The positions of retinal injection sites between genotypes are not
statistically distinct.
(B) Box plots illustrating the distributions of TZ locations. The top and bottom
edges of each box are the 25th and 75th percentile, respectively. The horizon-
tal line within each box is the median value. The vertical ‘‘whiskers’’ extend
above and below each box to the most divergent point within three times
the interquartile value. Filled circles are outliers. The distribution of TZ posi-
tions for p75+/+ and p75 fl/fl; cre-negative are not different. However, p75/
and p75 fl/fl; a-cre mice have TZ distributions significantly shifted anteriorly.
Mann-Whitney U test p values for the pairs indicated: n.s., not significant;
*p < 0.01; **p < 0.001.
(C) Borders of R-eGFP labeling superimposed on a dorsal view of the SC for
the p75+/+; a-cre; R-eGFP cases in Figures 6D and 8D (red). Two representa-
tive p75/; a-cre; R-eGFP cases (blue; from Figures 6E and 6F) illustrate the
anterior shift of the nasal domain (Nd). The p75 fl/fl; a-cre; R-eGFP case shown
in Figure 8E is illustrated in green. Note the large anterior shift of the Nd and
a reduced central domain (Cd).
(D) Average projection domain areas superimposed on a dorsal view of the SC.
The lines indicate the average AP positions for borders of eGFP labeling for754 Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc.limited to nasal and temporal retina and is not evident elsewhere
in the retinocollicular pathway (Marquardt et al., 2001; Baumer
et al., 2002), themapping phenotypes in the conditional and con-
stitutive p75 knockout mice are due to the loss of p75 from RGC
axons.
DISCUSSION
Reverse signaling through ephrin-As on RGC axons is implicated
in the development of the retinocollicular map (Rashid et al.,
2005) and in several other axonal projections (Knoll et al., 2001;
Cutforth et al., 2003; Marquardt et al., 2005). However, because
ephrin-As are GPI-linked proteins and lack an intracellular do-
main, they require a transmembrane signaling partner to initiate
the intracellular pathways that carry out their functions. Here, we
show that p75NTR is a signaling partner for ephrin-As and
activates an intracellular cascade that mediates the repellent
effects of ephrin-A reverse signaling on RGC axons required
for their proper guidance and mapping.
We show that p75 is expressed in RGCs and that p75 protein is
present in their axons in vivo at the appropriate developmental
stages to mediate guidance and mapping. In addition, p75 co-
localizes with ephrin-As along retinal axons and complexes
with ephrin-As in caveolae. Further, this association of p75 and
ephrin-A results in a functional signaling complex that when ac-
tivated by EphA binding to ephrin-As leads to increased levels
within caveolae of phosphorylated Fyn. Our demonstration that
EphA binds ephrin-A but not p75 indicates that EphAs are not li-
gands per se for p75, but through its association with ephrin-As,
p75 acts as coreceptor, or signaling partner, for them and is
required to activate their reverse signaling pathway. We also
find that the increased phosphorylation and recruitment of Fyn
to caveolae is dependent upon p75, which itself is recruited to
caveolae upon EphA binding ephrin-A.
Functional evidence for the p75-ephrin-A signaling complex
that we describe is provided by our in vitro axon guidance assays
showing that p75 is required for the repulsion of retinal axons by
EphA. In contrast, p75 is not required for the repulsion of retinal
p75+/+; a-cre; R-eGFP mice (red) and p75 fl/fl; a-cre; R-eGFP mice (green).
The values for p75+/+ cases (red) indicate the area of the SC each domain
occupies, whereas the values for p75 fl/fl; a-cre cases (green) represent the
percentage change from wild-type. There is a significant expansion and ante-
rior shift of the Nd (p < 0.01) and a concomitant significant decrease in the Cd in
p75 fl/fl; a-cre mice compared to control mice (p < 0.01).
(E) In wild-type mice, ephrin-As expressed in the retina (green gradient) and
along retinal ganglion cell (RGC) axons interact with EphAs (blue gradient) in
the SC. In addition, p75 is expressed in the retina (orange) and along RGC
axons and acts as an ephrin-A signaling partner. Therefore, p75 complexes
with ephrin-As along RGC axons and, upon binding EphAs in the SC, trans-
duces a repellent ephrin-A reverse signal (red gradient) that parallels the AP
gradient of EphA in the SC. Thus, nasal (N) RGC axons, expressing high levels
of ephrin-As, form a TZ in posterior SC, which expresses low levels of EphAs.
(F) In p75 mutant mice, an ephrin-A signaling partner is lacking from the retina.
Thus, the repellent ephrin-A reverse signal is reduced (diminished red gradi-
ent), allowing nasal RGC axons to form anteriorly shifted TZs (sTZ). The
expression patterns of ephrin-As and EphAs are unchanged in p75 mutant
mice. Therefore, the formation of sTZs in areas of high EphA expression is
due to the loss of the ephrin-A signaling partner, p75, and the concomitant
reduction in repellent ephrin-A reverse signal.
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quired for the repellent guidance activity mediated by ephrin-A
reverse signaling but is not required for the repellent guidance
activity mediated by EphA forward signaling. A recent report
suggested that the sensitivity of axons in peripheral nerves to
the repellent activity of Sema3A is enhanced in p75 knockout
mice (Ben-Zvi et al., 2007). However, we do not find evidence
for an analogous role for p75 in RGC axons; that is, the lack of
p75 does not lead to increased sensitivity to ephrin-A in stripe
assays and that EphA forward signaling appears unaffected.
We also demonstrate that p75 is required for appropriate to-
pographic mapping of RGC axons in the SC, by analyzing mice
constitutively null for p75 or in which floxed alleles of p75 are se-
lectively deleted from retina. In both p75 mutants, essentially all
RGC axons aberrantly terminate anterior to their topographically
appropriate position in the SC. This anterior shift in the termina-
tions of p75-deficient RGC axons is the predicted outcome if the
repellent activity of ephrin-A reverse signaling along the AP axis
of the SC is diminished and p75 mediates this signaling (Figures
9E and 9F). In conclusion, the findings from each set of experi-
ments in our study support the conclusion that p75 complexes
with ephrin-A in RGC axon membranes and that p75 is required
for the transduction of a repellent signal to RGCaxonswhen axo-
nally expressed ephrin-A binds EphA.
p75/ mice have normal retinal morphology and numbers of
RGCs (Harada et al., 2006), andwe find no obvious defects in the
retina or SC in either p75/mice or p75 fl/fl; a-cre mice, includ-
ing the expression of ephrin-As, EphAs, and RGC markers. The
a-cre mice used to delete p75 from retina in the conditional
p75 knockout mice have the important feature that cre-recombi-
nase is not expressed in the SC or anywhere in the visual path-
way outside of the retina (Marquardt et al., 2001; Baumer
et al., 2002). In addition, the early phases of map development
appear similar in p75 mutants compared to wild-type mice.
These observations, the similarity in mapping defects in the
two distinct p75 mutant lines, and the consistency of the map-
ping defects in p75 mutant mice with results from our in vitro
axon guidance assays show that the aberrant phenotypes are
due to the lack of p75 in RGC axons and are not due to second-
ary effects.
The aberrant mapping that we observe in the p75 mutant mice
is very consistent and is the predicted phenotype for a dimin-
ished action of ephrin-A reverse signaling. Our finding that the
mapping defect is characterized by the formation of a relatively
normal appearing TZ at an aberrant anterior position in the SC in-
dicates that p75-deficient RGC axons are affected in a uniform
manner, with essentially all RGC axons exhibiting a diminished
response to ephrin-A repulsion. However, the magnitude of the
anterior shift of the terminations of p75-deficient RGC axons
might be viewed as subtle. It is possible that the anterior shift
in terminations in p75 mutant mice is limited by the action of an-
other signaling partner for ephrin-A partially redundant with p75,
for example TROY, a transmembrane receptor that shares fea-
tures with p75 (Park et al., 2005). But, even if p75 is essentially
completely responsible for mediating the repellent effect of eph-
rin-A reverse signaling, as indicated by our findings using the
protein stripe assay, we would expect the observed phenotype
because other mechanisms that influence AP mapping are stillintact, including competitive interactions between axons, EphA
forward signaling, and ‘‘redundant’’ mapping mechanisms sug-
gested to explain phenotypes in ephrin-A and EphA mutants
(Frisen et al., 1998; Feldheim et al., 2000; Pfeiffenberger et al.,
2006). Because essentially all p75-deficient RGC axons are af-
fected in a uniform manner, the competitive balance between
them would be retained and would act to limit the magnitude
of the anterior shift of their terminations. For example, competi-
tive interactions limit the aberrant posterior shift in the termina-
tions of RGC axons genetically engineered to express higher
levels of EphA and therefore experience higher levels of repellent
EphA forward signaling (Brown et al., 2000).
The first experimental evidence for ephrin-A reverse signaling
in the retinocollicular projection was reported by Rashid et al.
(2005) based on the protein stripe assay and an analysis of
EphA7 knockout mice. EphA7, as well as EphA3 and EphA4, is
expressed in a high-to-low AP gradient in the SC, but EphA7 is
not expressed in retina. In EphA7 knockout mice, a proportion
of nasal RGC axons target to anterior SC rather than their appro-
priate TZ in posterior SC (Rashid et al., 2005). However, the pro-
portion of nasal RGC axons that mistarget is small, and most
project to their topographically correct site in posterior SC. In
contrast, in p75 mutants we find that essentially all RGC axons
mistarget anterior to their appropriate position in the SC, but
the magnitude of the anterior shift is relatively small. Thus, in
terms of appearance of the ectopic terminations, the EphA7 phe-
notype stands out because the subset of aberrantly projecting
axons substantially mistarget, and the ectopic TZ that they
form can be compared directly to the appropriate TZ that most
RGCs form in the same SC. However, in terms of the proportion
of axons that exhibit the aberrant phenotype, the p75 phenotype
is more robust than the EphA7 phenotype.
Further, the EphA7 mutant phenotype (Rashid et al., 2005) is
intriguing and perhaps unexpected because only one of several
EphAs with a high-to-low AP graded expression is eliminated
from the SC, and the small proportion of RGC axons affected
mistarget to anterior SC that retains high EphA expression. An in-
terpretation that explains the EphA7 mutant phenotype is that
a small subset of RGCs responds differently to EphA7 than
to EphA3 and EphA4. Although a basis for such a differential
response has not been reported, RGCs are a heterogeneous
population, with some RGC subsets comprising as little as 1%
of the population (Hattar et al., 2002).
The classic function of p75 is as anNTR. BDNF, a neurotrophin
ligand for the high-affinity NTR, TrkB, also binds p75 and has
a general role as a growth promoter of RGC axon arbors in the
retinotectal projection in Xenopus (Cohen-Cory and Fraser,
1995; Alsina et al., 2001). Thus, p75 may have a role as an
NTR in retinocollicular development, although the TrkB mutant
has been reported to have a normal retinocollicular map (Rohrer
et al., 2001). Regardless, the internal consistency of our findings
indicate that the phenotypes we find are due to p75 complexing
with ephrin-A to mediate the repellent effect of ephrin-A reverse
signaling, rather than p75 mediating growth promoting effects of
BDNF. For example, in the stripe assay, wild-type retinal axons
are strongly repelled by EphAs, but p75 null retinal axons are
not affected, though in vitro, explants from wild-type and p75
null mice extend the same number of axons and their averageNeuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc. 755
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RGC axons exhibit their normal, initially exuberant growth across
the SC. Thus, in the absence of p75, axon repulsion due to eph-
rin-A reverse signaling is lost, but general features of axon
growth are normal. In conclusion, p75-deficient retinal axons
exhibit normal outgrowth but selectively lose their repellent
response to EphAs, indicating that our findings are not due to
the loss of a trophic effect of p75 but are due to the specific
loss of the repellent effect of ephrin-A reverse signalingmediated
by p75.
The reports of roles for ephrin-A reverse signaling in the path-
finding of spinal motor axons (Marquardt et al., 2005) and the
mapping of olfactory receptor axons (Cutforth et al., 2003), which
also express p75 (Carson et al., 2005; Domeniconi et al., 2007)
suggest the possibility that p75 acts as a signaling partner with
ephrin-As in other developing projection systems. In addition,
Fyn, which is a prominent component of the p75-ephrin-A signal-
ing pathway, is also an important contributor to the signaling
pathways of other guidance molecules, including netrin/DCC
and sema3A (Sasaki et al., 2002; Liu et al., 2004; Meriane
et al., 2004). Thus, it is likely that p75 acts broadly as a partner
for ephrin-A reverse signaling and potentially other families of
axon guidancemolecules and their signaling pathways, suggest-
ing that both p75 and Fyn are involved in integrating multiple sig-
naling pathways to provide coherent guidance information.
EXPERIMENTAL PROCEDURES
Immunohistochemistry
Anesthetized mice were perfused with 4% paraformaldehyde (PF), dissected,
and cryoprotected in 30% sucrose. Cryostat sections (20 mm) were processed
with antibodies and receptor affinity probes from R&D Systems (anti-ephrin-
A2, AF603; anti-ephrin-A5, AF3743; ephrin-A5-Fc, 374-EA) and Santa Cruz
(anti-p75, sc-6188; Brn3.2, sc-6026). Some retinal sections were labeled
with anti-GFP antibodies (Molecular Probes, A11122). Retinal axons and 293
cells grown in vitro were fixed with 4% PF in PBS for 10–15 min, washed,
and processed with the reagents above as well anti-Fc antibody (Jackson
Immuno, 309-166-008) and EphA7-Fc (R&D Systems, 608-A7).
Immunoprecipitation
For Figure 2A, mouse retinas were lysed in RIPA buffer (150mMNaCl, 1%NP-
40, 0.5% DOC, 0.1% SDS, 50 mM Tris [pH 8.0]). Lysates were immunoprecip-
itated with anti-p75 intracellular domain antibody (Buster, a gift from Philip
A. Barker, McGill University) or anti-ephrin-A2 antibody (R&D Systems,
AF603). Immunoprecipitations were performed using ExactaCruz F and C
kits (Santa Cruz, sc-45043 and sc-45040) to decrease IgG bands. Samples
were analyzed using SDS-PAGE and western blots. For detection of p75 and
ephrin-A2, anti-p75 antibody (Buster) and anti-ephrin-A2 antibody (Santa
Cruz, L-20, sc-912) were used, respectively. For Figure 2B, PC12 cells were
transfected with linearized V5-tagged ephrin-A2 construct by TransFectin lipid
reagent (Biorad, 170-3352) and selected by puromycin (2 mg/ml) for at least 14
days. Colonies were picked and characterized by immunocytochemistry and
western blots. PC12 and stably transfected V5-ephrin-A2/PC12 cells were
lysed in RIPA buffer and immunoprecipitated with either anti-p75 (Buster) or
anti-V5 antibody (Invitrogen, R960-25). For detection of p75 and V5-ephrin-
A2, anti-p75 antibody (Buster) and anti-V5 antibody (Invitrogen) were used.
For Figure 2C, 293T cells were transiently transfected with cMyc-tagged p75
and/or V5-tagged ephrin-A5 or ephrin-A2 constructs by TransFectin. Cells
were lysed in RIPA buffer and immunoprecipitated with either anti-cMyc anti-
body (Santa Cruz, 9E10, sc-40) or anti-V5 antibody (Invitrogen). For detection
of p75 and V5-ephrin-A2/5, anti-p75 antibody (Buster) and anti-V5 antibody
(Invitrogen) were used.756 Neuron 59, 746–758, September 11, 2008 ª2008 Elsevier Inc.Isolation of Caveolae
Stably transfected 293 cell lines (ephrin-A2, p75, and ephrin-A2/p75) were
made by transfectingwith linearized V5-tagged ephrin-A2 and/or cMyc tagged
p75 constructs using TransFectin and selected by puromycin (2 mg/ml) and/
or G418 (400 mg/ml) for at least 14 days. Colonies were picked and character-
ized by immunocytochemistry and western blots. Detergent-resistant mem-
brane fractions containing caveolae were prepared by modifying a procedure
originally described by Higuchi et al. (2003). Cells were grown to 90% conflu-
ence and serum-starved for 18 hr before treatment. Cells were treated with ei-
ther human-Fc (R&D systems, 110-HG, 2 mg/ml) or EphA7-Fc (R&D Systems,
608-A7, 2 mg/ml) for 10 min at 37C, then lysed on ice with 1 ml of 0.5% Brij-58
(Sigma) in buffer containing 10 mM Tris (pH 7.5), 1 mM EDTA, 150 mM NaCl,
10% glycerol, phosphatase inhibitor cocktail I and II, and protease inhibitor
cocktail (Sigma). Lysed cells were scraped from plates into individual tubes
and kept on ice for 30 min. Lysates were adjusted to 40% sucrose, 2 ml of
the mixture was placed in the bottom of an SW41Ti ultracentrifuge tube (Beck-
man), and overlaid with 8 ml of 30% sucrose and 2 ml of distilled water. All
steps from lysis to centrifugation were performed at 4C. After centrifugation
(16 hr, 35,000 rpm, 4C), 1 ml fractions were collected from the top to the bot-
tom (numbered from 1 to 12). The proteins in each fraction were precipitated
for concentration and sucrose removal. Briefly, 600 ml methanol was added
to 150 ml of each fraction. After thorough mixing, 150 ml of chloroform was
added. After vortexing, 450 ml of water was added, vortexed again, and centri-
fuged for 5min at full speed in amicrocentrifuge. The upper aqueous layer was
discarded, 650 ml of methanol added, and each tube was inverted three times.
After 5 min at full speed in a microcentrifuge, all liquid was removed and the
pellets were air-dried. Equal volume of Laemmli’s sample buffer (30 ml) was
added, samples were heated at 100C for 5 min, and prepared for SDS-
PAGE and western blot analyses. For detection of tyrosine phosphorylation,
Fyn, p75, V5-tagged ephrin-A2, flotillin-1 and GM1, phosphotyrosine-specific
antibody 4G10 (a gift from Tony Hunter, Salk Institute), anti-Fyn antibody
(Santa Cruz, sc-16), anti-p75 intracellular domain antibody (Buster), anti-V5
antibody (Invitrogen, R960-25), anti-flotillin-1 antibody (BD Transduction Lab-
oratories, 610820) and CTX-HRP (Invitrogen, C34780) were used.
Mice
p75 null mutants were described previously (Lee et al., 1992). To generate p75
conditional mutants, two LoxP sites were introduced into the p75 locus to flank
exon 3 through homologous recombination in embryonic stem cells (Z. Chen,
T.-C.S., N. Harada,W. Lin, and K.-F.L., unpublished data). p75 conditional mu-
tants were crossed with a-cre transgenic mice (Marquardt et al., 2001) gener-
ously provided by Peter Gruss. In some cases the ROSA-GAP43-eGFP allele
was also present (mice generously provided by Martyn Goulding; Sapir et al.,
2004). Animal protocols were approved by the Salk Institute Animal Care and
Use Committee and conform to NIH guidelines.
Stripe Assays
Retinas from P0–P2 mice were dissected, flattened onto a nitrocellulose filter,
and cut into strips 150–400 mmwide. Strips were plated, RGC side down, onto
glass coverslips or plastic dishes coated with alternating stripes of human-Fc
or EphA7-Fc and human-Fc or ephrin-A5-Fc and human-Fc (R&D Systems
110-HG; 15–30 mg/ml) and laminin. Stripes were made essentially as de-
scribed (Hornberger et al., 1999; Rashid et al., 2005). After 2–4 days, explants
were stained with carboxyfluorescein diacetate, succinimidyl ester (fluores-
cent vital dye; Molecular Probes), examined, photographed, and scored inde-
pendently by two investigators blind to experimental condition, lane content,
and genotype of the explant source. A score of zero indicates no discernible
choice; one indicates any detectable bias; two indicates a clear bias; three in-
dicates a strong and significant choice for a significant majority of axons; four
indicates an essentially complete choice for one lane. Pixel values were deter-
mined by thresholding each grayscale photo using Adobe Photoshop until
pixels representing axons were white and background was black. Pixels
clearly representing debris were converted to background. Pixels were
counted in each lane and normalized for lane width. The modified Sholl inter-
section analysis was performed by delineating the edge of each explant and
points 100 mm, 300 mm, 600 mm, 900 mm away. Blind to genotype, lane condi-
tion, and lane position, all intersections between axons and the transposed
Neuron
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boundaries were overlaid, and the position of each intersection point was
assigned to a lane and normalized for lane width. The coefficient of choice is
defined as the total pixels representing axons or intersections on control lanes
minus that on the second human-Fc lane, or the EphA7-Fc or ephrin-A5-Fc
lanes, divided by total pixels or intersections. A coefficient of one indicates
an absolute choice for the control lane, a coefficient of zero indicates no
choice, and a negative coefficient of choice indicates a choice for the second
human-Fc or EphA7-Fc or ephrin-A5-Fc lane.
Axon Tracing and Analysis
Focal injections of the lipophilic, fluorescent axon tracer DiI (Molecular Probes)
were made via pressure injection through a glass micropipette tip into the ret-
ina and allowed to transport for 16–24 hr. Mice were perfused, dissected, and
axon labeling photographed. Some midbrains were sectioned on a vibratome
at 100–200 mm. The focal nature and fidelity of all injections was determined by
retinal flat-mounts examined under fluorescence. All labeled axons originated
from a single focal location in every case reported.
Analyses of TZ position, DiI injection location, and eGFP domains in the SC
were performed on digital images in Adobe Photoshop or NIH ImageJ software
and analyzed with Excel or KaleidaGraph software. The center of the DiI injec-
tion and TZ were used for the analyses and determined to be the center of
a circumscribed circle. For the analysis of eGFP-labeled projection domains,
the SC was divided into ten equal segments along the LM axis. The anterior
and posterior borders of the central domain were determined in each segment
by thresholding at three times the average pixel value of an arbitrarily selected
areawithin the central domain of that segment. Segments were combined, and
pixel values counted in the three defined domains. Values for domain sizes are
normalized. Total SC area is not statistically different between genotypes.
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